Paralemmin anticorps (N-Term)
-
- Antigène Voir toutes Paralemmin (PALM) Anticorps
- Paralemmin (PALM)
-
Épitope
- N-Term
-
Reactivité
- Humain
-
Hôte
- Lapin
-
Clonalité
- Polyclonal
-
Conjugué
- Cet anticorp Paralemmin est non-conjugé
-
Application
- Western Blotting (WB)
- Purification
- Purified
- Immunogène
- PALM antibody was raised in rabbit using the N terminal of PALM as the immunogen
- Top Product
- Discover our top product PALM Anticorps primaire
-
-
- Indications d'application
-
WB: 0.2-1 µg/mL
Optimal conditions should be determined by the investigator. - Commentaires
-
PALM Blocking Peptide, catalog no. 33R-4884, is also available for use as a blocking control in assays to test for specificity of this PALM antibody
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Concentration
- Lot specific
- Buffer
- Lyophilized powder. Add 50 µL of distilled water. Final antibody concentration is 1 mg/mL in PBS buffer.
- Conseil sur la manipulation
- Avoid repeated freeze/thaw cycles.
- Stock
- 4 °C/-20 °C
- Stockage commentaire
- Store at 4 °C, following reconstitution, aliquot and store at -20 °C.
-
- Antigène
- Paralemmin (PALM)
- Autre désignation
- PALM (PALM Produits)
- Sujet
- This gene encodes a member of the paralemmin protein family. The product of this gene is a prenylated and palmitoylated phosphoprotein that associates with the cytoplasmic face of plasma membranes and is implicated in plasma membrane dynamics in neurons and other cell types. Several alternatively spliced transcript variants have been identified, but the full-length nature of only two transcript variants has been determined. Synonyms: Polyclonal PALM antibody, Anti-PALM antibody, paralemmin antibody, KIAA0270 antibody.
- Pathways
- cAMP Metabolic Process, Regulation of G-Protein Coupled Receptor Protein Signaling
-